Press Releases
FDA approves linagliptin tablets for the treatment of type 2 diabetes
Boehringer Ingelheim and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used...
Press Releases
The European Commission Approves Pfizer’s Revatio for the Treatment of Pulmonary Arterial Hypertension in Children
Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission for the treatment of pediatric patients aged 1 to 17...
Press Releases
The American Society of Clinical Oncology and CollabRx Partner to Develop Online Apps for Planning Cancer Treatment
The American Society of Clinical Oncology (ASCO), the world's leading professional organization representing physicians who care for people with cancer, and CollabRx, an organization...
Press Releases
Almac Introduces selectAZyme
Almac’s biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of...
Press Releases
ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of Bepotastine Besilate Nasal Spray
ISTA Pharmaceuticals, Inc. announced positive, topline results from its Phase 2 dose-ranging, environmental clinical trial of bepotastine besilate nasal spray for the treatment of...
Press Releases
Wockhardt receives US FDA approval for generic version of Aricept tablets
Pharmaceutical and biotechnology major Wockhardt has received tentative approval from the United States Food & Drug Administration (US FDA) for marketing 5mg and 10mg...
Press Releases
CIT/ABC acquires assets of LAB Research Inc.
Applied Biology Company (ABC), the holding company of CIT Safety & Health Research Laboratories (CIT), a leading player among European preclinical CROs, announces today...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read